Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Contraception ; 81(4): 309-15, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20227547

RESUMEN

BACKGROUND: The purpose of this study was to evaluate the effect of long-term use of oral contraceptives (OC) containing 0.20 mg of ethinylestradiol (EE) combined with 0.15 mg of gestodene (GEST) on the peak aerobic capacity and at the anaerobic threshold (AT) level in active and sedentary young women. STUDY DESIGN: Eighty-eight women (23+/-2.1 years old) were divided into four groups - active-OC (G1), active-NOC (G2), sedentary-OC (G3) and sedentary-NOC (G4) - and were submitted to a continuous ergospirometric incremental test on a cycloergometer with 20 to 25 W min(-1) increments. Data were analyzed by two-way ANOVA with Tukey post hoc test. Level of significance was set at 5%. RESULTS: The OC use effect for the variables relative and absolute oxygen uptake VO(2) mL kg-(1) min(-1); VO(2), L min(-1), respectively), carbon dioxide output (VCO(2), L min(-1)), ventilation (VE, L min(-1)), heart rate (HR, bpm), respiratory exchange ratio (RER) and power output (W) data, as well as the interaction between OC use and exercise effect on the peak of test and at the AT level did not differ significantly between the active groups (G1 and G2) and the sedentary groups (G3 and G4). As to the exercise effect, for all variables studied, it was noted that the active groups presented higher values for the variables VO(2), VCO(2), VE and power output (p<.05) than the sedentary groups. The RER and HR were similar (p>.05) at the peak and at the AT level between G1 vs. G3 and G2 vs. G4. CONCLUSIONS: Long-term use of OC containing EE 0.20 mg plus GEST 0.15 mg does not affect aerobic capacity at the peak and at the AT level of exercise tests.


Asunto(s)
Umbral Anaerobio/efectos de los fármacos , Anticonceptivos Orales Combinados/efectos adversos , Etinilestradiol/efectos adversos , Norpregnenos/efectos adversos , Adulto , Anticonceptivos Orales Combinados/administración & dosificación , Estudios Transversales , Etinilestradiol/administración & dosificación , Ejercicio Físico , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Norpregnenos/administración & dosificación , Consumo de Oxígeno/efectos de los fármacos , Conducta Sedentaria , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA